Hand Dexterity in Children: Administration and Normative Values of the Functional Dexterity Test

Gogola, Gloria R.; Velleman, Paul F.; Xu, Shuai; Morse, Adrianne M.; Lacy, Brianna; Aaron, Dorit H.

doi:10.1016/j.jhsa.2013.08.123

Cited by 41 publications

(29 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Innovative scoring strategies are characteristic of tools such as the FDT and SD test. The FDT is commercially available with pediatric normative data 13 while, the SD test is being examined for clinical utility. As the data becomes available the SD test could provide the pediatric clinician with a unique outcome measure of dynamic force control.…”

Section: Discussionmentioning

confidence: 99%

“…13 This scoring strategy allows for statistically valid numerical comparisons against other quantitative functional variables and graphing of rate of completion along a continuous age scale. Although useful this scoring strategy is rarely used in dexterity testing.…”

Section: Dexterity Measurementmentioning

confidence: 99%

“…13 Although there are other taxonomies for IHM, 15-17 the classification scheme by Exner 18-19 is described here by three main features: shift (movement across finger pads), translation (finger-to-palm and palm-to-finger), and rotation (simple and complex). The three components of IHM are assessed with the task of picking up a coin and placing it in a vertical slot.…”

Section: Dexterity Measurementmentioning

confidence: 99%

“…Inefficient movements are reflected in decreased speed, thus do not require the additional adjustment for penalties. 13 The FDT is sensitive enough to detect functional inefficiencies of IHM, and thus penalties have been eliminated from pediatric FDT scoring.…”

Section: Dexterity Measurementmentioning

confidence: 99%

“…13 There are no gender differences through 17 years of age. Dominant hands are faster than non-dominant hands at all ages and the difference between the two remains constant.…”

Section: Dexterity Measurementmentioning

confidence: 99%

See 4 more Smart Citations

Innovative evaluation of dexterity in pediatrics

Duff

Aaron²,

Gogola

et al. 2015

Journal of Hand Therapy

Self Cite

View full text Add to dashboard Cite

Study Design Review paper Introduction Hand dexterity is multifaceted and essential to the performance of daily tasks. Timed performance and precision demands are the most common features of quantitative dexterity testing. Measurement concepts such as rate of completion, in-hand manipulation and dynamic force control of instabilities are being integrated into assessment tools for the pediatric population. Purpose To review measurement concepts inherent in pediatric dexterity testing and introduce concepts that are infrequently measured or novel as exemplified with two assessment tools. Methods Measurement concepts included in common assessment tools are introduced first. We then describe seldom measured and novel concepts embedded in two instruments; the Functional Dexterity Test (FDT) and the Strength-Dexterity (SD) Test. Discussion The inclusion of measurement concepts and tools that are infrequently measured or novel in our repertoire of assessments potentially aids our understanding of atypical dexterity contributing to the design of targeted therapy programs.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Dexterity Measurementmentioning

confidence: 99%

Section: Dexterity Measurementmentioning

confidence: 99%

Section: Dexterity Measurementmentioning

confidence: 99%

“…13 There are no gender differences through 17 years of age. Dominant hands are faster than non-dominant hands at all ages and the difference between the two remains constant.…”

Section: Dexterity Measurementmentioning

confidence: 99%

See 3 more Smart Citations

Innovative evaluation of dexterity in pediatrics

Duff

Aaron²,

Gogola

et al. 2015

Journal of Hand Therapy

Self Cite

View full text Add to dashboard Cite

show abstract

Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study

Harmatz

Mengel

Geberhiwot

et al. 2016

American J of Med Genetics Pt A

View full text Add to dashboard Cite

Efficacy and safety of elosulfase alfa enzyme replacement therapy (ERT) were assessed in an open‐label, phase 2, multi‐national study in Morquio A patients aged ≥5 years unable to walk ≥30 meters in the 6‐min walk test. Patients received elosulfase alfa 2.0 mg/kg/week intravenously for 48 weeks. Efficacy measures were functional dexterity, pinch/grip strength, mobility in a modified timed 25‐foot walk, pain, quality of life, respiratory function, and urine keratan sulfate (KS). Safety/tolerability was also assessed. Fifteen patients received elosulfase alfa, three patients discontinued ERT due to adverse events (two were grade 3 drug‐related adverse events, the other was not drug‐related), and two patients missed >20% of planned infusions; 10 completed treatment through 48 weeks and received ≥80% of planned infusions (Modified Per Protocol [MPP] population). The study population had more advanced disease than that enrolled in other trials. From baseline to week 48, MPP data showed biochemical efficacy (urine KS decreased 52.4%). The remaining efficacy results were highly variable due to challenges in test execution because of severe skeletal and joint abnormalities, small sample sizes, and clinical heterogeneity among patients. Eight patients showed improvements in one or more outcome measures; several patients indicated improvements not captured by the study assessments (e.g., increased energy, functional ability). The nature of adverse events was similar to other elosulfase alfa studies. This study illustrates the considerable challenges in objectively measuring impact of ERT in very disabled Morquio A patients and highlights the need to examine results on an individual basis. © 2016 The Authors. American Journal of Medical Genetics Part A Published by Wiley Periodicals, Inc.

show abstract

Therapy Management of Children with Congenital Anomalies of the Upper Extremity

Gibson

2014

Congenital Anomalies of the Upper Extremity

View full text Add to dashboard Cite

Hand Dexterity in Children: Administration and Normative Values of the Functional Dexterity Test

Cited by 41 publications

References 15 publications

Innovative evaluation of dexterity in pediatrics

Innovative evaluation of dexterity in pediatrics

Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study

Therapy Management of Children with Congenital Anomalies of the Upper Extremity

Contact Info

Product

Resources

About